Prospective validation of a transcriptomic severity classifier among patients with suspected acute infection and sepsis in the ED

2022-05-06T07:20:44-07:00

Galtung, N, et al. European Journal of Emergency Medicine. April 2022.

Diagnostic host gene expression analysis by quantitative reverse transcription loop-mediated isothermal amplification to discriminate between bacterial and viral infections

2022-03-02T14:39:48-08:00

Remmel M, et al. Clinical Chemistry. Feb 2022.

Pilot study of a novel serum mRNA gene panel for diagnosis of acute septic arthritis

2022-03-02T14:40:28-08:00

Schultz B, et al. World Journal of Orthopedics. Dec 2019.

A transcriptomic severity metric that predicts clinical outcomes in critically ill surgical sepsis patients

2022-02-18T17:26:37-08:00

Brakenridge, S. et al. Critical Care Explorations. Oct 2021.

The optimization and biological significance of a 29-host-immune-mRNA panel for the diagnosis of acute infections and sepsis

2021-11-09T14:20:54-08:00

He, Y. et al. J. Pers. Med. June 2021.

A novel 29-messenger RNA host-response assay from whole blood accurately identifies bacterial and viral infections in the ED

2021-07-09T10:58:57-07:00

Bauer, W. et al. Critical Care Medicine. June 2021.

A multi-mRNA host-response molecular blood test for the diagnosis and prognosis of acute infections and sepsis

2021-07-28T13:14:51-07:00

Ducharme, J. et al. J. Pers. Med. Dec 2020.

A 29-mRNA host response test from blood accurately distinguishes bacterial and viral infections among ED patients

2021-07-09T11:02:46-07:00

Safarika, A. et al. medRxiv. Dec 2020

Cost impact model of a novel multi-mRNA host response assay for diagnosis and risk assessment of acute infections and sepsis in the ED

2021-07-09T11:11:02-07:00

Schneider JE, Romanowsky J, et al. JHEOR. 2020.

A generalizable 29-mRNA neural-network classifier for acute bacterial and viral infections

2021-07-09T11:11:28-07:00

Mayhew M, et al. Nature Communications. Mar 2020.

Go to Top